Journey Medical Corporation Common Stock
DERM
DERM: Journey Medical Corp is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm, etc.
moreShow DERM Financials
Recent trades of DERM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by DERM's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Process for production of glycopyrronium tosylate Jan. 03, 2023
-
Patent Title: Processes for making, and methods of using, glycopyrronium compounds Jun. 07, 2022
-
Patent Title: Compositions and methods for treating rosacea and acne May. 10, 2022
-
Patent Title: Glycopyrrolate salts Apr. 05, 2022
-
Patent Title: Glycopyrrolate salts Apr. 05, 2022
Federal grants, loans, and purchases
Followers on DERM's company Twitter account
Number of mentions of DERM in WallStreetBets Daily Discussion
Recent insights relating to DERM
Recent picks made for DERM stock on CNBC
ETFs with the largest estimated holdings in DERM
Flights by private jets registered to DERM